Page last updated: 2024-11-07
tetrahydrocortisone and Adrenogenital Syndrome
tetrahydrocortisone has been researched along with Adrenogenital Syndrome in 1 studies
Adrenogenital Syndrome: Abnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| DECOURT, J | 1 |
| MICHARD, JP | 1 |
| BAULIEU, E | 1 |
| TOURNEUR, R | 1 |
| LOUCHART, J | 1 |
| LEVEAU, J | 1 |
Other Studies
1 other study available for tetrahydrocortisone and Adrenogenital Syndrome
| Article | Year |
|---|---|
[Congenital adrenal hyperplasia of the pseudohermaphroditic type; attempts at inhibition by tetrahydrocortisone and fludrocortisone].
Topics: Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Disorders of Sex Development; Fludrocortiso | 1956 |